Literature DB >> 2219573

Epidemiology of prostate cancer.

A W Meikle1, J A Smith.   

Abstract

Available epidemiologic data do not allow targeting of specific populations for prostate cancer screening or early detection programs. Although certain strong factors have been identified (age, race, location), none sufficiently defines high-risk groups in whom recommendations should differ from those of other age-matched patients. Certainly, a strong familial tendency has been identified, but the relative contribution of genetic and environmental factors in these patients remains unclear. Some hypotheses on the pathogenesis of prostate cancer are possible based on the available data. Genetic factors appear to be permissive, as are hormonal influences, which are partially regulated by genetics. Environmental factors appear to be promotional in genetically susceptible men. Dietary fat may also be an important promotional factor in genetically susceptible men. Dietary factors appear to exert some influence by modulating sex hormone concentration. Several factors demand more investigation and understanding of the epidemiology of prostate cancer. The relative frequency of the disease and the increasing death rate from prostate cancer are of concern. The similarities in the incidence of latent prostate cancer among various groups with strong differences in the rate of clinically apparent disease raise significant issues regarding potential lifestyle or environmental promotional factors. Further understanding of the pathogenesis of prostate cancer may allow a refinement and definition of programs for prevention and early detection of the disease.

Entities:  

Mesh:

Year:  1990        PMID: 2219573

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  13 in total

1.  Decision tree-based modeling of androgen pathway genes and prostate cancer risk.

Authors:  Jill S Barnholtz-Sloan; Xiaowei Guan; Charnita Zeigler-Johnson; Neal J Meropol; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-14       Impact factor: 4.254

Review 2.  Prostate cancer, screening, and prostate-specific antigen: promise or peril?

Authors:  J D Voss
Journal:  J Gen Intern Med       Date:  1994-08       Impact factor: 5.128

Review 3.  Clinical and economic considerations in the treatment of prostate cancer.

Authors:  E Varenhorst; P Carlsson; K Pedersen
Journal:  Pharmacoeconomics       Date:  1994-08       Impact factor: 4.981

4.  Genetics of prostate cancer.

Authors:  Kai Qi Zhang; Sherry A Salzman; D J Reding; Brian K Suarez; William J Catalona; James K Burmester
Journal:  Clin Med Res       Date:  2003-01

5.  Molecular mechanisms involving prostate cancer racial disparity.

Authors:  David Hatcher; Garrett Daniels; Iman Osman; Peng Lee
Journal:  Am J Transl Res       Date:  2009-04-20       Impact factor: 4.060

6.  Analysis of Gleason grade and scores in 90 Nigerian Africans with prostate cancer during the period 1994 to 2004.

Authors:  U G Ugare; I E Bassey; P G Jibrin; I A Ekanem
Journal:  Afr Health Sci       Date:  2012-03       Impact factor: 0.927

7.  PET imaging of VPAC1 expression in experimental and spontaneous prostate cancer.

Authors:  Kaijun Zhang; Mohan R Aruva; Nylla Shanthly; Christopher A Cardi; Satish Rattan; Chirag Patel; Christopher Kim; Peter A McCue; Eric Wickstrom; Mathew L Thakur
Journal:  J Nucl Med       Date:  2007-12-12       Impact factor: 10.057

8.  Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States).

Authors:  K L Danley; J L Richardson; L Bernstein; B Langholz; R K Ross
Journal:  Cancer Causes Control       Date:  1995-11       Impact factor: 2.506

9.  Prostate cancer: perceptions of African-American males.

Authors:  J H Price; T L Colvin; D Smith
Journal:  J Natl Med Assoc       Date:  1993-12       Impact factor: 1.798

Review 10.  Cancer of the prostate.

Authors:  D P Dearnaley
Journal:  BMJ       Date:  1994-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.